ANDROGENETIC ALOPECIA (AGA)
Clinical trials for ANDROGENETIC ALOPECIA (AGA) explained in plain language.
Never miss a new study
Get alerted when new ANDROGENETIC ALOPECIA (AGA) trials appear
Sign up with your email to follow new studies for ANDROGENETIC ALOPECIA (AGA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a daily supplement stop hair loss? new study investigates
Disease control CompletedThis study tested whether a dietary supplement (capsules and drink) could reduce hair loss in 240 adults with two common types of hair loss: androgenetic alopecia and chronic telogen effluvium. Participants took the supplement or a placebo daily for 6 months and had their hair de…
Matched conditions: ANDROGENETIC ALOPECIA (AGA)
Phase: NA • Sponsor: Lacer S.A. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New hair loss drug shows promise in early trial
Disease control CompletedThis study tested a new medicine called CG2001 for male pattern baldness in Chinese men aged 18 to 65. The goal was to see if it helps regrow hair and is safe to use. 110 participants took part, and the main measure was change in hair count after 24 weeks.
Matched conditions: ANDROGENETIC ALOPECIA (AGA)
Phase: PHASE2 • Sponsor: Beijing Dayspring Pharmaceutical Technology Co., Ltd • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Hair loss hope? study tests latanoprost acid in women
Symptom relief CompletedThis study tested whether a cosmetic product containing latanoprost acid can improve hair growth in women aged 18-60 with female pattern hair loss or chronic telogen effluvium. 29 women applied one of three strengths of the product daily for 6 months. The main goal was to see if …
Matched conditions: ANDROGENETIC ALOPECIA (AGA)
Phase: NA • Sponsor: Medical University of Warsaw • Aim: Symptom relief
Last updated May 17, 2026 11:35 UTC